| NCT01492361 | A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin | COMPLETED | PHASE3 | 2011-11 | 2018-05 | 2018-05 |
| NCT01047683 | Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL | COMPLETED | PHASE3 | 2009-12 | 2011-07 | 2010-10 |
| NCT01047501 | Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL) | COMPLETED | PHASE3 | 2009-12 | 2011-02 | 2011-02 |
| NCT00146211 | TREND-HD - A Trial of Ethyl-EPA (Miraxionâ„¢) in Treating Mild to Moderate Huntington's Disease | COMPLETED | PHASE3 | 2005-09 | 2007-07 | 2007-08 |